0001607062-18-000350.txt : 20181015 0001607062-18-000350.hdr.sgml : 20181015 20181015161720 ACCESSION NUMBER: 0001607062-18-000350 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181003 FILED AS OF DATE: 20181015 DATE AS OF CHANGE: 20181015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Purcell Richard David Jr. CENTRAL INDEX KEY: 0001639306 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 181122397 MAIL ADDRESS: STREET 1: 65 FAIR HAVEN ROAD CITY: FAIR HAVEN STATE: NJ ZIP: 07704 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 BUSINESS PHONE: 416-364-2551 MAIL ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 4 1 ownership.xml X0306 4 2018-10-03 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001639306 Purcell Richard David Jr. 10102 USA TODAY WAY MIRAMAR FL 33025 1 1 0 0 SVP of Research & Drug Develop Stock Option (right to buy) 2.23 2018-10-03 4 A 0 4500 0 A 2028-10-03 Common Stock 4500 4500 D The option vests in three equal annual installments beginning on October 3, 2018. /s/ Richard David Purcell, Jr. 2018-10-15